Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No substantive study details appear to have changed.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor software version update with no observable changes to the study details.SummaryDifference0.1%

- Check30 days agoChange DetectedGlossary is now shown on the page; update metadata now includes 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3 with no changes to study content or essential features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedLocations section updated to include Guangdong and Hubei locations; revision noted as v3.3.3.SummaryDifference0.4%

- Check94 days agoChange DetectedRevision: v3.3.2 is now shown, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.